Logo
Menu
  • Home
  • Practice Areas
    • Medical Malpractice LawHelping New York Medical Malpractice, Personal Injury Cases
    • Close
  • New York Injury News
  • Press release
    • Injury News
    • Motor Vehicle Accidents
    • Personal Injury Accidents
    • Construction Accidents
    • Medical Malpractice
    • Premises Liability
    • Product Liability
    • Work Related Fire Fighter Deaths
    • Wrongful Death
    • Close
  • Ask A Lawyer
  • Free Case Evaluation
  • Sitemap

Home » Injury News » FDA product safety recall: US Oftalmi eye/nasal drops potentially unsterile

FDA product safety recall: US Oftalmi eye/nasal drops potentially unsterile

New Source: JusticeNewsFlash.com
Legal News for Product Liability Attorneys. The FDA announced the recall of potentially unsterile eye and nasal drops manufactured by US Oftalmi.

News for product liability attorneys- Consumer safety hazards prompted recall of eye/nasal drops, FDA announced.

Hallandale, FL—US Oftalmi Corp., in cooperation with the U.S. Food and Drug Administration (FDA) http://www.fda.gov announced the voluntary recall of 15 mL plastic bottles of over-the-counter Camolyn Eye Drops and Fisiolin Nasal Drops. The FDA announced the recall on Friday, April 2, 2010 after it was discovered that the products be unsterile, subsequently posing safety hazards to consumers.

According to the FDA, the recall was issued “due to conditions at the manufacturing facility that cannot assure the sterility of the products. Products that are non-sterile have the potential to cause eye infections, which may be sight threatening”. Although the recalled products have yet to cause any injuries, illnesses or harmful effects, US Oftalmi issued the recall as a safety precaution. The chances of consumers suffering any unpleasant reactions from the recalled eye and nasal drops were reportedly deemed to be slim and unlikely, however, the firm did not want to take any chances with regard to the safety of the product. US Oftalmi has stopped production, importation and distribution of the recalled eye and nasal drops for the time being.

Product names, lot numbers, expiration dates, and UPC codes affected by the recall are listed below:

•CAMOLYN HOMEOPATHIC
Lot #: 049036, 087934
Expiration dates: 05/2011, 08/2009
UPC codes: 591196, 00446

•CAMOLYN PLUS, NAPHAZOLINE + CHAMOMILE 15 ml.
Lot #: 037691, 097420
Expiration Dates: 03/2010, 10/2010
UPC codes: 66482, 00018

•CAMOLYN REFRESH 15 ml.
Lot #: 116636, 107610
Expiration Dates: 11/2009, 11/2010
UPC codes: 66482, 00020

•CAMOLYN-A, NAPHAZOLINE + PHENIRAMINE 15 ml
Lot #: 057063, 058962, 106606, 099487
Expiration Dates: 05/2009 ,04/2010, 10/2008, 09/2011
UPC codes: 66482, 00019

•FISIOLIN NASAL DROPS SODIUM CHLORIDE PEDIATRIC USES 15 ml.
Lot #: 028659
Expiration Dates: 03/2011
UPC codes: 591196, 00375

Consumers have been urged to discard affected eye and nasal drops immediately. US Oftalmi may be contacted at (954) 338-6891 from 8 a.m. to 4:30 p.m. EST Monday through Friday for more information concerning the product safety recall. According to US Oftalmi president, “The company is committed to taking all necessary measures to remedy these production issues, and protect the trust physicians and patients place in our products.”

Legal News Reporter: Sandra Quinlan- Legal News for Product Liability Lawyers. News Source: JusticeNewsFlash.com – Press Release Distribution

It's only fair to share...Pin on Pinterest
Pinterest
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
Share on Facebook
Facebook
Email this to someone
email
Print this page
Print
April 9, 2010   injurynewsreporter
Injury News
×

  • Louisville, Kentucky aviation accident: Michigan man injured in plane crash
  • Forget what you heard about YouTube lawyer marketing and read this – Part 2

Recent News and Press Coverage

  • Todd Stager, Esteemed SEO for Lawyers Expert, Embarks on a New Journey with His Own SEO Firm March 11, 2024
  • Attorney Dan Powell Examines the Financial Challenges of Not Having a Living Trust: Implications for Business Owners February 16, 2024
  • Adam P. Boyd Leads Innovative Masterclass on Strategies for Law Firm Growth February 14, 2024
  • David Dardashti Donates to Expand Research on Sexual Violence Among Children and Develop Prevention Protocol. January 29, 2024
  • A Queens County Supreme Court jury rendered a verdict for $7 million In Medical Negligence Case December 1, 2023
  • Record-Breaking $700,000 Verdict by Mezrano Law Firm Redefines Justice in Personal Injury Cases November 30, 2023
  • The Law Office of Richard Roman Shum Unveils Comprehensive Guide on New York Divorce Laws October 12, 2023
  • Brooklyn Estate Planning Attorney Yana Feldman Offers Free Services for Israel-bound Volunteers October 12, 2023
  • Google Drops FAQ Rich Snippets so Custom Legal Marketing Released a Video to Help Lawyers Understand Why October 5, 2023
  • Bronx Injury Attorneys Explain How Damages Are Calculated August 22, 2023
  • ZeroRisk Cases, Inc. Utilizes Cutting-Edge Technology to Target High-Quality Plaintiffs in Talcum Powder Litigation August 15, 2023
  • ZeroRisk Cases, Inc. Unveils Advanced Website Platform and Digital Marketing Strategy for Increased Law Firm Growth August 15, 2023
  • The Search Engine Domination Society Achieves a 300% Increase in Client Calls for NYC Personal Injury Lawyer August 11, 2023
  • Federal Tax Credits ERC Updates and Releases New Informational Videos about ERC July 6, 2023
  • Who is Liable for Dooring Accidents? Bronx E-bike Attorney Glenn A. Herman Explains July 4, 2023
  • Weizhen Tang Announces Publication of Law and Justice: My Struggle During His 2026 Mayoral Campaign July 4, 2023
  • Enhancing Data Compliance with AdvisorVault: Heritage Brokerage’s 17a-4 Trusted Partner July 3, 2023
  • Attorney Beau Harlan: The Champion of Justice Unveils Comprehensive Legal Services for Vancouver, WA and Portland, OR June 28, 2023
  • The Legal Process for Motor Vehicle Accidents in New York City June 2, 2023
  • NYC Bicycle Accident Lawyer Explains Winning an Accident Claim March 20, 2023

Archives

  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • August 2023
  • July 2023
  • June 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • October 2022
  • September 2022
  • July 2022
  • June 2022
  • May 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • July 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • December 1999
  • January 1970
New York Injury News
1512 Schorr Place
PMB #35071
Bronx, NY 10469
718-210-1007
Copyright © 2025 New York Injury News
Go to mobile version